Skandinaviska Enskilda Banken (SEB)
RVMD icon

Skandinaviska Enskilda Banken (SEB)’s Revolution Medicines RVMD Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-29,705
Closed -$1.09M – 870
2025
Q2 		$1.09M Hold
29,705
– – ﹤0.01% 642
2025
Q1 		$1.05M Hold
29,705
– – 0.01% 628
2024
Q4 		$1.28M Hold
29,705
– – 0.01% 631
2024
Q3 		$1.35M Hold
29,705
– – 0.01% 642
2024
Q2 		$1.15M Hold
29,705
– – 0.01% 627
2024
Q1 		$957K Hold
29,705
– – ﹤0.01% 661
2023
Q4 		$852K Buy
29,705
+10,938
+58% +$263K ﹤0.01% 716
2023
Q3 		$519K Buy
+18,767
New +$557K ﹤0.01% 764

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s RVMD Position: Q3 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Revolution Medicines (RVMD) in Q3 2025, closing a stake of 29,705 shares — an estimated $1.09M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in RVMD in Q3 2023 and held it in 8 quarters. The position peaked at $1.35M in Q3 2024. 323 funds tracked by Wall St. Rank hold RVMD as of Q3 2025.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Revolution Medicines position as of Q3 2025 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 29,705 Revolution Medicines shares in Q3 2025, an estimated $1.09M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Revolution Medicines in Q3 2023 and held it in 8 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Revolution Medicines position peaked at $1.35M in Q3 2024.
  • 323 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2025, filed 7 Nov 2025.